These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 18536030)

  • 1. Interleukin-6 predicts recurrence and survival among head and neck cancer patients.
    Duffy SA; Taylor JM; Terrell JE; Islam M; Li Y; Fowler KE; Wolf GT; Teknos TN
    Cancer; 2008 Aug; 113(4):750-7. PubMed ID: 18536030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma: results of a multivariate prospective study.
    Tartour E; Deneux L; Mosseri V; Jaulerry C; Brunin F; Point D; Validire P; Dubray B; Fridman WH; Rodriguez J
    Cancer; 1997 Apr; 79(7):1401-8. PubMed ID: 9083163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of haptoglobin predicts recurrence in head and neck squamous cell carcinoma.
    Lee CC; Ho HC; Lee MS; Hung SK; Yu CC; Su YC
    Clin Chim Acta; 2010 Aug; 411(15-16):1116-21. PubMed ID: 20417195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matched analysis of survival in patients with squamous cell carcinoma of the head and neck diagnosed before and after 40 years of age.
    Pytynia KB; Grant JR; Etzel CJ; Roberts D; Wei Q; Sturgis EM
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):869-73. PubMed ID: 15262765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-culture of head and neck squamous cell carcinoma spheroids with autologous monocytes predicts prognosis.
    Kross KW; Heimdal JH; Olsnes C; Olofsson J; Aarstad HJ
    Scand J Immunol; 2008 Apr; 67(4):392-9. PubMed ID: 18282234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03.
    Rabinovitch R; Grant B; Berkey BA; Raben D; Ang KK; Fu KK; Cooper JS;
    Head Neck; 2006 Apr; 28(4):287-96. PubMed ID: 16287132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
    Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
    J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
    Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
    J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head and neck cancer recurrence and mortality in nonselective cyclooxygenase inhibitor users.
    Gillespie MB; Moody MW; Lee FS; Poole LJ; Hornig JD; Lathers D; Young MR; Day TA
    Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):28-31. PubMed ID: 17224518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma.
    Heimdal JH; Aarstad HJ; Olofsson J
    Laryngoscope; 2000 Mar; 110(3 Pt 1):402-7. PubMed ID: 10718427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma.
    Liao WC; Lin JT; Wu CY; Huang SP; Lin MT; Wu AS; Huang YJ; Wu MS
    Clin Cancer Res; 2008 Jan; 14(2):428-34. PubMed ID: 18198221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein.
    Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
    Clin Cancer Res; 2005 May; 11(9):3257-64. PubMed ID: 15867221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the histologic risk model in a new cohort of patients with head and neck squamous cell carcinoma.
    Brandwein-Gensler M; Smith RV; Wang B; Penner C; Theilken A; Broughel D; Schiff B; Owen RP; Smith J; Sarta C; Hebert T; Nason R; Ramer M; DeLacure M; Hirsch D; Myssiorek D; Heller K; Prystowsky M; Schlecht NF; Negassa A
    Am J Surg Pathol; 2010 May; 34(5):676-88. PubMed ID: 20414102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble Tie-2 receptor levels independently predict locoregional recurrence in head and neck squamous cell carcinoma.
    Homer JJ; Greenman J; Drevs J; Marme D; Stafford ND
    Head Neck; 2002 Aug; 24(8):773-8. PubMed ID: 12203803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma.
    Tse GM; Chan AW; Yu KH; King AD; Wong KT; Chen GG; Tsang RK; Chan AB
    Ann Surg Oncol; 2007 Dec; 14(12):3558-65. PubMed ID: 17929099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial and physical correlates of survival and recurrence in patients with head and neck carcinoma: results of a 6-year longitudinal study.
    De Boer MF; Van den Borne B; Pruyn JF; Ryckman RM; Volovics L; Knegt PP; Meeuwis CA; Mesters I; Verwoerd CD
    Cancer; 1998 Dec; 83(12):2567-79. PubMed ID: 9874465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of mitotic and apoptotic index and the DNA cytometry in head and neck cancer.
    Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
    Neoplasma; 2005; 52(3):199-207. PubMed ID: 15875080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage.
    Kao J; Lavaf A; Teng MS; Huang D; Genden EM
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):362-70. PubMed ID: 18164833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
    Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
    Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.